MURPHY MATTHEW B. (General Counsel) purchased 36.9% of their position (20K shares) of NAUTILUS BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $12.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/5/2025ACC: 0001865778-25-000003
Officer· General Counsel
Since Jun 2021
+20K
Net shares
Net buyer
$12.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+20K
Price / share
$0.64
Trade value
$12.86K
% of position
36.9%
9/4/2025
54.14K→74.14K
Total
Net shares
+20K
Net value
$12.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/4/2025 | P · Purchase | +20K | $0.64 | $12.86K | 36.9% | 54.14K | 74.14K |
| Total | +20K | $12.86K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned1.25K
Total
1.25K direct1.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.25K | Direct |
| Total | 1.25K | 1.25K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported